These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 38176268)

  • 1. Ginsenoside Rg5 inhibits lipid accumulation and hepatocyte apoptosis via the Notch1 signaling pathway in NASH mice.
    Li N; Zhu C; Fu R; Ma X; Duan Z; Fan D
    Phytomedicine; 2024 Feb; 124():155287. PubMed ID: 38176268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel Alisma orientale extract alleviates non-alcoholic steatohepatitis in mice via modulation of PPARα signaling pathway.
    Xie Y; Jin Y; Wen J; Li G; Huai X; Duan Y; Ni F; Fu J; Li M; Li L; Yan M; Cao L; Xiao W; Yang H; Wang ZZ
    Biomed Pharmacother; 2024 Jul; 176():116908. PubMed ID: 38850668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acetyl-CoA carboxylase inhibition disrupts metabolic reprogramming during hepatic stellate cell activation.
    Bates J; Vijayakumar A; Ghoshal S; Marchand B; Yi S; Kornyeyev D; Zagorska A; Hollenback D; Walker K; Liu K; Pendem S; Newstrom D; Brockett R; Mikaelian I; Kusam S; Ramirez R; Lopez D; Li L; Fuchs BC; Breckenridge DG
    J Hepatol; 2020 Oct; 73(4):896-905. PubMed ID: 32376414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ginsenoside Rg
    Shi Y; Chen J; Qu D; Sun Q; Yu Y; Zhang H; Liu Z; Sha J; Sun Y
    Nutrients; 2024 Mar; 16(6):. PubMed ID: 38542753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calycosin attenuates triglyceride accumulation and hepatic fibrosis in murine model of non-alcoholic steatohepatitis via activating farnesoid X receptor.
    Duan X; Meng Q; Wang C; Liu Z; Liu Q; Sun H; Sun P; Yang X; Huo X; Peng J; Liu K
    Phytomedicine; 2017 Feb; 25():83-92. PubMed ID: 28190475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myeloid-specific deletion of chitinase-3-like 1 protein ameliorates murine diet-induced steatohepatitis progression.
    Kim AD; Kui L; Kaufmann B; Kim SE; Leszczynska A; Feldstein AE
    J Mol Med (Berl); 2023 Jul; 101(7):813-828. PubMed ID: 37166517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ginsenoside Rk3 Regulates Nonalcoholic Steatohepatitis by Modulation of Intestinal Flora and the PI3K/AKT Signaling Pathway in C57BL/6 Mice.
    Guo M; Zhu C; Fu R; Ma X; Duan Z; Fan D
    J Agric Food Chem; 2023 Jun; 71(24):9370-9380. PubMed ID: 37288986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neferine ameliorates nonalcoholic steatohepatitis through regulating AMPK pathway.
    Wang MY; Zhang SS; An MF; Xia YF; Fan MS; Sun ZR; Zhang LJ; Zhao YL; Sheng J; Wang XJ
    Phytomedicine; 2023 Jun; 114():154798. PubMed ID: 37031639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Silybin Alleviates Hepatic Steatosis and Fibrosis in NASH Mice by Inhibiting Oxidative Stress and Involvement with the Nf-κB Pathway.
    Ou Q; Weng Y; Wang S; Zhao Y; Zhang F; Zhou J; Wu X
    Dig Dis Sci; 2018 Dec; 63(12):3398-3408. PubMed ID: 30191499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kangtaizhi Granule Alleviated Nonalcoholic Fatty Liver Disease in High-Fat Diet-Fed Rats and HepG2 Cells via AMPK/mTOR Signaling Pathway.
    Zhang J; Du H; Shen M; Zhao Z; Ye X
    J Immunol Res; 2020; 2020():3413186. PubMed ID: 32884949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatocyte CD36 protects mice from NASH diet-induced liver injury and fibrosis via blocking N1ICD production.
    Li Y; Zhang L; Jiao J; Ding Q; Li Y; Zhao Z; Luo J; Chen Y; Ruan X; Zhao L
    Biochim Biophys Acta Mol Basis Dis; 2023 Oct; 1869(7):166800. PubMed ID: 37423141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmaceutical Efficacy of Gypenoside LXXV on Non-Alcoholic Steatohepatitis (NASH).
    Lee JH; Oh JY; Kim SH; Oh IJ; Lee YH; Lee KW; Lee WH; Kim JH
    Biomolecules; 2020 Oct; 10(10):. PubMed ID: 33050067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tilianin alleviates lipid deposition and fibrosis in mice with nonalcoholic steatohepatitis by activating the PPARα/Nnat axis.
    Ke F; Wu X; Zheng J; Li C
    Drug Dev Res; 2023 Aug; 84(5):922-936. PubMed ID: 37052239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluvastatin attenuates hepatic steatosis-induced fibrogenesis in rats through inhibiting paracrine effect of hepatocyte on hepatic stellate cells.
    Chong LW; Hsu YC; Lee TF; Lin Y; Chiu YT; Yang KC; Wu JC; Huang YT
    BMC Gastroenterol; 2015 Feb; 15():22. PubMed ID: 25886887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Morroniside delays the progression of non-alcoholic steatohepatitis by promoting AMPK-mediated lipophagy.
    Zhang C; Tong Q; Liu K; Mao T; Song Y; Qu Y; Chen X; Qiu Z
    Phytomedicine; 2024 Jul; 129():155703. PubMed ID: 38723527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A network pharmacology approach: Inhibition of the NF-κB signaling pathway contributes to the NASH preventative effect of an Oroxylum indicum seed extract in oleic acid-stimulated HepG2 cells and high-fat diet-fed rats.
    Sun W; Liu P; Yang B; Wang M; Wang T; Sun W; Wang X; Zheng W; Song X; Li J
    Phytomedicine; 2021 Jul; 88():153498. PubMed ID: 33640247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lycopus lucidus Turcz. ex Benth. Attenuates free fatty acid-induced steatosis in HepG2 cells and non-alcoholic fatty liver disease in high-fat diet-induced obese mice.
    Lee MR; Yang HJ; Park KI; Ma JY
    Phytomedicine; 2019 Mar; 55():14-22. PubMed ID: 30668424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Yanggan Jiangmei Formula alleviates hepatic inflammation and lipid accumulation in non-alcoholic steatohepatitis by inhibiting the NF-κB/NLRP3 signaling pathway.
    Wu Y; Zhou J; Zuo X; Kuang Y; Sun L; Zhang X
    Chin J Nat Med; 2024 Mar; 22(3):224-234. PubMed ID: 38553190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of AMPK by triptolide alleviates nonalcoholic fatty liver disease by improving hepatic lipid metabolism, inflammation and fibrosis.
    Huang R; Guo F; Li Y; Liang Y; Li G; Fu P; Ma L
    Phytomedicine; 2021 Nov; 92():153739. PubMed ID: 34592488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FGF21 protects against hepatic lipotoxicity and macrophage activation to attenuate fibrogenesis in nonalcoholic steatohepatitis.
    Liu C; Schönke M; Spoorenberg B; Lambooij JM; van der Zande HJP; Zhou E; Tushuizen ME; Andreasson AC; Park A; Oldham S; Uhrbom M; Ahlstedt I; Ikeda Y; Wallenius K; Peng XR; Guigas B; Boon MR; Wang Y; Rensen PCN
    Elife; 2023 Jan; 12():. PubMed ID: 36648330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.